By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – BioSearch Technologies today said that it has licensed patents covering oligonucleotide components to Intelligent Medical Devices (IMDx).

According to the Novato, Calif.-based firm, it has licensed to IMDx access to patents covering its BHQ, CAL Fluor, and Quasar technologies. It also will manufacture cGMP oligonucleotides for Cambridge, Mass.-based IMDx for human in vitro diagnostic use.

Financial and other terms of the alliance were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.